Trials / Recruiting
RecruitingNCT06857877
Arlington Aging Study
Arlington Study of Healthy Aging
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 770 (estimated)
- Sponsor
- The University of Texas at Arlington · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to learn about the mechanisms causing functional decline with age, using exercise science, neuroscience, and remote monitoring. Specific aims include: Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability. Aim 2: Determine the effects of personal and societal factors on aging. Aim 3: Examine the influence of racial/ethnic and sex differences on the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.
Detailed description
Subjects will be asked to participate in two study visits that may last up to 5 hours each. In some cases, additional visits may be needed to accommodate their schedule, and/or the schedule of the study team. All participants will provide informed consent prior to participating in the study procedures such as demographic, medical history, risk factor assessment; questionnaires; geographic information system analysis; blood pressure measurements; assessment of aerobic exercise capacity, cognitive function; olfactory testing; Dual X-Ray absorbency, fasting followed by venous blood draw, vascular function assessment; testing of muscle strength; short physical performance battery; functional mobility; and remote monitoring. The order of procedures and visits may change depending on participant, staff, equipment, and infrastructure availability/needs. Moreover, procedures may be repeated for data quality purposes, if deemed necessary by the investigators.
Conditions
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2030-12-31
- Completion
- 2030-12-31
- First posted
- 2025-03-05
- Last updated
- 2026-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06857877. Inclusion in this directory is not an endorsement.